Antitumor effects of isolated hypoxic hepatic perfusion (IHHP) with high-dose TNF against colonic liver metastases in a rat model

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2455-2459

  Nakamoto, Takeru ^a   Inagawa, Hiroyuki ^a   Nishizawa, Takashi ^a   Honda, Teruko ^a   Kanou, Junko ^a   Nagasue, Naofumi ^a   Soma, Gen Ichiro ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

5 FU; Isolated hypoxic hepatic perfusion; Melphalan; TNF SAM2; Unresectable liver tumor

Indexed keywords

FLUOROURACIL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HYPOXEMIA; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANOXIA; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FLUOROURACIL; LIVER NEOPLASMS; MALE; PERFUSION; RATS; RATS, INBRED F344; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036332380     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Neoplasms of the liver
2. Neoplasms, liver
3. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
4. Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cells
5. A new rat colon cancer cell line metastasizes spontaneously: Biologic characteristics and chemotherapeutic response
6. Homeostasis as regulated by activated macrophage. I. Lipopolysaccharide from wheat flour: Isolation, purification and some biological activities
7. Homeostasis as regulated by activated macrophage. II. LPS of plant origin other than wheat flour and their concomitant bacteria
8. Dual role of tumor necrosis factor-a in angiogenesis
9. Evidence for the involvement of endothelial cell integrin αVb3 in the disruption of the tumor vasculature induced by TNF and IFN-γ
10. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα)
11. VWF release and platelet aggregation in human melanoma after perfusion with TNF-α
12. Tumor necrosis factor
13. Synergistic antitumor effects of TNF-α and melphalan in an isolated limb perfusion model of rat sarcoma: A histopathologic, immunohisto-chemical and electron microscopic study
14. High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation
15. Regional therapy of melanoma
16. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
17. Isolated limb perfusion with high-dose tumor necrosis factor-a in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial
18. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results
19. Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome
20. Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma
21. TNFα in isolated perfusion systems: Success in the limb, developments for the liver credits, debits and future perspectives